Concepedia

Erkan Yuca

EY

Statistics

Publications

16

Citations

1K

H-Index

15

Active since

2012

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Oslo University Hospital

Baylor College of Medicine

Jackson Laboratory

University of Oslo

Erkan Yuca is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, molecular oncology, and medicine.

Publications per year

2012–2024

16

Publications

16

Oxidative Phosphorylation Is a Metabolic Vulnerability in Chemotherapy-Resistant Triple-Negative Breast Cancer

Kurt W. Evans, Erkan Yuca, Stephen M. Scott et al. · Cancer Research · 2021 · 157 citations · Full text

, , +17

Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment

Hua Sun, Song Cao, R. Jay Mashl et al. · Nature Communications · 2021 · 109 citations · Full text

, , +17

Therapeutic Silencing of Bcl-2 by Systemically Administered siRNA Nanotherapeutics Inhibits Tumor Growth by Autophagy and Apoptosis and Enhances the Efficacy of Chemotherapy in Orthotopic Xenograft Models of ER (−) and ER (+) Breast Cancer

İbrahim Tekedereli, S. Neslihan Alpay, Uǧur Akar et al. · Molecular Therapy — Nucleic Acids · 2013 · 101 citations · Full text

, , +17

Molecular circuit involving KLK4 integrates androgen and mTOR signaling in prostate cancer

Yang Jin, Su Qu, Martina Tesikova et al. · Proceedings of the National Academy of Sciences · 2013 · 71 citations · Full text

, , +17

First in class dual MDM2/MDMX inhibitor ALRN-6924 enhances antitumor efficacy of chemotherapy in TP53 wild-type hormone receptor-positive breast cancer models

Seyed Pairawan, Ming Zhao, Erkan Yuca et al. · Breast Cancer Research · 2021 · 68 citations · Full text

, , +13

1–5 of 16